Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.09B | 6.46B | 6.49B | 7.67B | 6.21B | Gross Profit |
3.68B | 3.21B | 5.14B | 6.47B | 5.27B | EBIT |
2.33B | 1.99B | 2.37B | 3.71B | 2.75B | EBITDA |
2.33B | 2.52B | 3.14B | 3.91B | 2.94B | Net Income Common Stockholders |
2.04B | 1.79B | 1.56B | 3.08B | 2.37B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.65B | 2.07B | 1.76B | 1.52B | 2.15B | Total Assets |
13.47B | 12.28B | 11.64B | 12.52B | 10.66B | Total Debt |
278.70M | 397.90M | 329.60M | 249.20M | 154.10M | Net Debt |
-2.37B | -1.67B | -1.43B | -1.27B | -2.00B | Total Liabilities |
2.02B | 1.99B | 1.96B | 2.26B | 1.39B | Stockholders Equity |
10.35B | 9.51B | 8.84B | 9.02B | 7.71B |
Cash Flow | Free Cash Flow | |||
1.26B | 911.20M | 2.12B | 3.21B | 1.70B | Operating Cash Flow |
1.69B | 1.22B | 2.36B | 3.45B | 1.92B | Investing Cash Flow |
-177.50M | -527.20M | -41.50M | -1.10B | -36.30M | Financing Cash Flow |
-936.60M | -1.08B | -2.08B | -2.99B | -1.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $49.96B | 15.07 | 2.49% | 1.11% | 11.38% | 39.25% | |
80 Outperform | $6.50B | 16.12 | 8.69% | 3.78% | 18.85% | 7.96% | |
75 Outperform | $150.05B | 23.01 | 14.60% | 2.11% | 12.15% | 15.17% | |
72 Outperform | $7.16B | 13.59 | 5.32% | 4.89% | 3.97% | ― | |
70 Outperform | $22.29B | 10.93 | 19.76% | 4.77% | 9.80% | 17.87% | |
64 Neutral | $14.34B | 10.61 | 9.28% | 4.07% | 18.04% | -9.54% | |
64 Neutral | $10.28B | 30.00 | 3.03% | 6.30% | 9.48% | -65.57% |
T. Rowe Price will conduct an investor conference call and webcast on February 5, 2025, to discuss its earnings results for the periods ending December 31, 2024. This event aims to provide insights into the company’s financial performance, potentially impacting its operations and stakeholder perspectives.